Published by Josh White on 25th September 2024
(Sharecast News) - Shield Therapeutics announced promising results from its phase three paediatric clinical trial for 'Accrufer' and 'Ferracru', or ferric maltol, in treating iron deficiency anaemia (IDA) in children on Wednesday.
URL: http://www.digitallook.com/dl/news/story/34579139/...